
Theodoros Kelesidis MD PhD, MSc
HIV/AIDS Medicine, Transplant/Immunocompromised States
Associate Professor
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-633-5555
Fax+1 214-645-6757
Dr. Kelesidis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California Los AngelesMsc, Translational Research , Cum Laude, 2015 - 2016
- University of California Los AngelesPhD, Microbiology, Immunology, Molecular Genetics, Cum Laude, 2010 - 2013
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2009 - 2013
- St Elizabeth's Medical CenterResidency, Internal Medicine, 2006 - 2009
- Beth Israel Deaconess Medical CenterPost-Doctoral Fellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2006
- University of AthensClass of 2004, MD, Cum Laude
Certifications & Licensure
- TX State Medical License 2023 - 2026
- CA State Medical License 2009 - 2024
- MA State Medical License 2008 - 2015
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Start of enrollment: 2019 Apr 01
- Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV Start of enrollment: 2024 Mar 01
Roles: Contact, Principal Investigator
- An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness Start of enrollment: 2022 Apr 28
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Atherogenic Effects of Acute Electronic Cigarette Compared With Tobacco Cigarette Smoking in People Living With HIV: A Randomized Crossover Trial.Theodoros Kelesidis, Leila Fotooh Abadi, Isabelle Ruedisueli, Zoee U D'Costa, Holly R Middlekauff
Journal of the American Heart Association. 2025-04-01 - When cytokine storms collide: understanding hemophagocytic lymphohistiocytosis in human herpesvirus 8/Kaposi sarcoma herpesvirus-associated multicentric Castleman dise...Ramya Ramaswami, Theodoros Kelesidis, James J Goedert
AIDS. 2025-04-01 - Reduced high-density lipoprotein antioxidant function in patients with coronary artery disease and acute coronary syndrome.Benjamin Sasko, Linda Scharow, Rhea Mueller, Monique Jaensch, Werner Dammermann
JCI Insight. 2025-03-24
Press Mentions
- Urgent Warning as Study Finds Vaping Could Put Healthy Young People at Higher Risk of Developing a Severe DiseaseFebruary 10th, 2023
- Vaping Could Raise Teens' Odds for Severe COVIDFebruary 10th, 2023
- Smoking Tobacco, Vaping E-cigarettes May Raise Risk of COVID-19 in Healthy Young People, Says StudyFebruary 10th, 2023
- Join now to see all
Grant Support
- Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19UT SOUTHWESTERN MEDICAL CENTER2023–2026
- Targeting early instigators of vascular inflammation to prevent and/or delay vascular aging in chronic treated HIVUT SOUTHWESTERN MEDICAL CENTER2018–2025
- Targeting early instigators of vascular inflammation to prevent and/or delay vascular aging in chronic treated HIVUT SOUTHWESTERN MEDICAL CENTER2018–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: